From 26-28 October, 2010 the PDA Parenterals Conference will be held in Berlin.
This outstanding event will cover the very important topics:
Don´t miss this interesting conference in Berlin, Germany.
This guidance is intended to be the first of several guidances and regulations that FDA may issue to implement section 505D of the Act, and its issuance is intended to assist with the development of standards and systems for identification, validation, authentication, and tracking and tracing of prescription drugs. This guidance defines SNI for package-level identification only.
Check the Final Guidance for Industry! The document is there provided for online reading and in a printer friendly version.